Skip to main content

and
  1. No Access

    Article

    HLA haploidentical stem cell transplantation from HLA homozygous donors to HLA heterozygous donors may have lower survival rates than haploidentical transplantation from HLA heterozygous donors to HLA heterozygous donors: a retrospective nationwide analysis

    In HLA haploidentical stem cell transplantation, patients and donors usually share one HLA haplotype and have one different HLA haplotype (hetero-to-hetero). However, there are rare cases of transplantation fr...

    Keiko Fukunaga, Kazuhiro Ikegame, Hirohisa Nakamae in International Journal of Hematology (2024)

  2. Article

    Open Access

    Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide

    We previously conducted a randomized phase II trial of OCV-501, a WT1 peptide presented by helper T cells, in elderly AML (acute myeloid leukemia) patients in first remission, indicating no difference in 2-yea...

    Tomoki Naoe, Akiko Saito, Nahoko Hosono, Senji Kasahara in Cancer Immunology, Immunotherapy (2023)

  3. No Access

    Article

    Coombs’ test positive autoimmune hemolytic anemia accompanied by myelodysplastic syndrome that became Coombs’ test negative after azacitidine administration

    Shinya Yamada, Sayaka Kajikawa, Noriharu Nakagawa, Yukio Kondo in Annals of Hematology (2022)

  4. Article

    Effectiveness of hyperbaric oxygen therapy for virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation

    Although some studies have suggested the effectiveness of hyperbaric oxygen (HBO) therapy for hemorrhagic cystitis (HC) after allogeneic hematopoietic stem cell transplantation (HSCT), the role of HBO has not ...

    Kohei Hosokawa, Go Aoki, Kinya Ohata in International Journal of Hematology (2021)

  5. No Access

    Article

    Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients

    The global, randomized, open-label KEYNOTE-185 study closed early after an interim analysis showed an unfavorable benefit-risk profile with pembrolizumab plus lenalidomide and low-dose dexamethasone (Rd) versu...

    Naoki Takezako, Hiroshi Kosugi, Morio Matsumoto in International Journal of Hematology (2020)

  6. No Access

    Article

    Two unique HLA-A*0201 restricted peptides derived from cyclin E as immunotherapeutic targets in leukemia

    Immunotherapy targeting leukemia-associated antigens has shown promising results. Because of the heterogeneity of leukemia, vaccines with a single peptide have elicited only a limited immune response. Targetin...

    Hong He, Yukio Kondo, Ken Ishiyama, Gheath Alatrash, Sijie Lu, Kathryn Cox in Leukemia (2020)

  7. No Access

    Article

    Late response to low-dose imatinib in patients with chronic phase chronic myeloid leukemia

    Imatinib was the first BCR-ABL tyrosine kinase inhibitor to become clinically available. In this study, we retrospectively evaluated the long-term efficacy of low-dose imatinib (final maintenance dose <300 mg ...

    Akiyoshi Takami, Shigeki Ohtake, Eriko Morishita in International Journal of Hematology (2012)

  8. No Access

    Article

    TGF-β–FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia

    Chronic myeloid leukaemia (CML) is caused by a BCR-ABL fusion that generates a constitutively active tyrosine kinase. Although inhibition of tyrosine kinase with imatinib has been used successfully for CML the...

    Kazuhito Naka, Takayuki Hoshii, Teruyuki Muraguchi, Yuko Tadokoro, Takako Ooshio in Nature (2010)

  9. Article

    Erratum to: Cord blood transplantation using minimum conditioning regimens for patients with hematologic malignancies complicated by severe infections

    Takeshi Yamashita, Chiharu Sugimori, Ken Ishiyama in International Journal of Hematology (2009)

  10. No Access

    Article

    Cord blood transplantation using minimum conditioning regimens for patients with hematologic malignancies complicated by severe infections

    Patients with severe infections are thought to be ineligible for cord blood stem cell transplantation (CBT) because the conventional 5–6 day-conditioning regimens potentially makes them susceptible to fatal in...

    Takeshi Yamashita, Chiharu Sugimori, Ken Ishiyama in International Journal of Hematology (2009)

  11. No Access

    Article

    Living-Donor Lobar Lung Transplantation for Broncho-Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation: Does Bronchiolitis Obliterans Recur in Transplanted Lungs?

    We report a successful case of living-donor lobar lung transplantation (LDLLT) for therapy-resistant broncho-bronchiolitis obliterans (BBO) after allogeneic hematopoietic stem cell transplantation (HSCT). Bron...

    Hirokazu Okumura, Shigeki Ohtake, Yasuo Ontachi in International Journal of Hematology (2007)

  12. No Access

    Article

    Mycophenolate Mofetil Is Effective and Well Tolerated in the Treatment of Refractory Acute and Chronic Graft-versus-Host Disease

    We enrolled 11 patients with refractory graft-versus-host disease (GVHD) in a prospective trial evaluating the efficacy of mycophenolate mofetil (MMF). Four (67%) of the 6 patients with acute GVHD and all 5 pa...

    Akiyoshi Takami, Kanako Mochizuki, Hirokazu Okumura in International Journal of Hematology (2006)

  13. No Access

    Article

    Small follicular lymphoma arising near the ampulla of vater

    A 49-yr-old Japanese woman underwent upper gastrointestinal endoscopy because of nonspecific dyspepsia. Endoscopy revealed a flat elevated lesion about 15 mm in diameter adjacent to the duodenal papilla, the s...

    Takahiro Zenda MD, Takaharu Masunaga in International Journal of Gastrointestinal … (2005)